These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8595534)

  • 21. Health care utilization and cost among children with asthma who were enrolled in a health maintenance organization.
    Lozano P; Fishman P; VonKorff M; Hecht J
    Pediatrics; 1997 Jun; 99(6):757-64. PubMed ID: 9164766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative safety and costs of stepping down asthma medications in patients with controlled asthma.
    Rank MA; Liesinger JT; Branda ME; Gionfriddo MR; Schatz M; Zeiger RS; Shah ND
    J Allergy Clin Immunol; 2016 May; 137(5):1373-1379.e3. PubMed ID: 26506020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
    Chan J; Hui RL; Spence MM
    J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are young adults with asthma treated sufficiently with inhaled steroids? A population-based study of prescription data from 1991 and 1994.
    Gaist D; Hallas J; Hansen NC; Gram LF
    Br J Clin Pharmacol; 1996 Apr; 41(4):285-9. PubMed ID: 8730973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of risk factors and health outcomes among persons with asthma.
    Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
    J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administrative claims analysis of utilization and costs of care in health plan members with atopic dermatitis who had prior use of a topical corticosteroid and who initiate therapy with pimecrolimus or tacrolimus.
    Delea TE; Gokhale M; Makin C; Hussein MA; Vanderpoel J; Sandman T; Chang J; Sung J; Pinkston P; Gause D; Jackson M
    J Manag Care Pharm; 2007 May; 13(4):349-59. PubMed ID: 17506601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ratio of controller to total asthma medications: determinants of the measure.
    Broder MS; Gutierrez B; Chang E; Meddis D; Schatz M
    Am J Manag Care; 2010 Mar; 16(3):170-8. PubMed ID: 20225912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
    Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
    Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intervention to reduce unnecessary dispensing of short-acting {beta}-agonists in patients with asthma.
    Wong MD; Manley RT; Stettin G; Chen W; Salmun LM
    Ann Pharmacother; 2010 Apr; 44(4):623-9. PubMed ID: 20233916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing asthma care for Medicaid and non-Medicaid children in a health maintenance organization.
    Finkelstein JA; Barton MB; Donahue JG; Algatt-Bergstrom P; Markson LE; Platt R
    Arch Pediatr Adolesc Med; 2000 Jun; 154(6):563-8. PubMed ID: 10850502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cost analysis on the pattern of asthma prescribing in the UK.
    Neville RG; Pearson MG; Richards N; Patience J; Sondhi S; Wagstaff B; Wells N
    Eur Respir J; 1999 Sep; 14(3):605-9. PubMed ID: 10543282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?
    Holimon TD; Chafin CC; Self TH
    Drugs; 2001; 61(3):391-418. PubMed ID: 11293649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Administrative claims analysis of all-cause annual costs of care and resource utilization by age category for ulcerative colitis patients.
    Bickston SJ; Waters HC; Dabbous O; Tang BI; Rahman M
    J Manag Care Pharm; 2008 May; 14(4):352-62. PubMed ID: 18500913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health Care Utilization and Costs After Initiating Budesonide/Formoterol Combination or Fluticasone/Salmeterol Combination Among COPD Patients New to ICS/LABA Treatment.
    Davis JR; Kern DM; Williams SA; Tunceli O; Wu B; Hollis S; Strange C; Trudo F
    J Manag Care Spec Pharm; 2016 Mar; 22(3):293-304. PubMed ID: 27003559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The technology of metered-dose inhalers and treatment costs in asthma: a retrospective study of breath actuation versus traditional press-and-breathe inhalers.
    Langley PC
    Clin Ther; 1999 Jan; 21(1):236-53. PubMed ID: 10090438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inappropriate use of inhaled short acting beta-agonists and its association with patient health status.
    Hong SH; Sanders BH; West D
    Curr Med Res Opin; 2006 Jan; 22(1):33-40. PubMed ID: 16393428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs.
    Stempel DA; O'Donnell JC; Meyer JW
    J Allergy Clin Immunol; 2002 Mar; 109(3):433-9. PubMed ID: 11897987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergic rhinitis: a potential cause of increased asthma medication use, costs, and morbidity.
    Halpern MT; Schmier JK; Richner R; Guo C; Togias A
    J Asthma; 2004 Feb; 41(1):117-26. PubMed ID: 15046386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization, cost trends, and member cost-share for self-injectable multiple sclerosis drugs--pharmacy and medical benefit spending from 2004 through 2007.
    Kunze AM; Gunderson BW; Gleason PP; Heaton AH; Johnson SV
    J Manag Care Pharm; 2007; 13(9):799-806. PubMed ID: 18062731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.